# Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)

> **NCT00723645** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 279 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00723645
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-04
- **Final completion:** 2011-02
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2015-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00723645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00723645, "Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00723645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*